InvestorsHub Logo
Followers 5
Posts 280
Boards Moderated 0
Alias Born 08/29/2015

Re: kld2 post# 87521

Thursday, 01/12/2017 12:42:34 PM

Thursday, January 12, 2017 12:42:34 PM

Post# of 459519
I disagree, AVXL is different than other development stage Bio-techs.
They decided early on to not do an IPO, thereby reducing the information on what they were working on until a point was reached they were so far ahead of all others that catching up would not be feasible.
They decided to watch their costs by limiting labor, lab, research costs by outsourcing as much as possible, and therefore keeping costs to future customers lower and potential competition down because the price they could charge should be very competitive.
I think their model, as an organization design is the best in class, they have brought in a Board of directors, and Scientific Advisory Board that is nothing short of amazing. The best of the best.
One day the rest of the world will be touched by our company, yes every human being.
Cheers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News